Law360, New York (July 20, 2012, 10:30 PM ET) -- A unit of German medical technology conglomerate Fresenius SE & Co. KGaA aims to expand its transfusion business by purchasing Illinois-based blood collection device specialist Fenwal Inc. from its private equity founders, the parties announced Friday.
The deal, whose terms were not disclosed, marks the exit of Fenwal Inc. founders TPG Capital and Maverick Capital Ltd., which launched the company as an independent entity in 2007 after purchasing Baxter Healthcare Corp.’s transfusion therapies unit.
By acquiring Fenwal, Fresenius Kabi gains access to the Illinois company’s leading...
Fresenius Scoops Up PE-Owned Blood Collection Co.
To view the full article, take a free trial now.
